Meta Pixel

News and Announcements

Cirrus Materials Science successfully closes pre-series A capital round

  • Published October 18, 2019 12:00AM UTC
  • Publisher Wholesale Investor
  • Categories Company Updates

Cirrus Materials Science, an advanced functional coatings technology designer, announced that the company has closed a pre-series A financing round of approximately $1.8 million.

Cirrus is pleased to welcome a diverse group of new holders from New Zealand, Australia, and Singapore to the company. The pre-series A funding will accelerate rapid global growth and further functional coatings development.

Cirrus Materials has recently signed a deal with the US DoE. Today, customers in industries such as electric mobility and renewable energy are in the process of adopting Cirrus performance coatings solutions. The funding supports Cirrus’s sales and marketing activities in key markets such as North America, Southeast Asia, and Europe.

 

About Cirrus Materials Science

Cirrus is a New Zealand-based materials design business serving major manufacturing customers in Australasia, US, EU and Asia.

Register Interest

Capital Insights
From Outback to Boardroom: How SWAN Systems is Codifying Water Stewardship

From the arid deserts of Australia to the boardrooms of global tech giants, SWAN Systems is redefining water efficiency. By bridging the gap between field-level agronomics and autonomous irrigation control, the company is proving that “water-positive” targets can be met with science, data, and a 10x ROI commitment.

Capital Insights
The Ferrari of Immunotherapy: Chimeric’s High-Stakes Race to Cure Cancer

In the high-stakes world of biotechnology, the most sophisticated weapon against cancer isn’t a new chemical compound but the patient’s own immune system, re-engineered with the precision of a high-performance engine. “This particular CAR T is like a Ferrari,” says Dr. Rebecca McQualter, CEO of Chimeric Therapeutics (ASX: CHM). “It’s got two big engines on […]

Capital Insights
From Algae Pioneers to a Natural Revolution: The Second Act of WRS Bioproducts

As the US FDA prepares to phase out synthetic food colors by the end of 2026, WRS Bioproducts is stepping in to solve a looming supply crisis. Led by industry pioneer Harry Rosen, the company is leveraging 40 years of industrial algae farming expertise to scale production of natural, superior-quality beta-carotene, positioning itself as a vital supplier in the rapidly shifting global market for natural ingredients.

Join over 45,000+ sophisticated investors

Join Now